About Shionogi Pharma, Inc.

Patrick P. Fourteau President and Chief Executive Officer, Shionogi Pharma, Inc. Isao Teshirogi, Ph.D. President and Representative Director, Shionogi & Co., Ltd.

Shionogi Pharma, Inc., a Shionogi company, is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, and attention deficit/hyperactivity disorder (ADHD).

Founded in 1992 and headquartered in Atlanta, Georgia, Shionogi Pharma employs more than 1,000 people. The company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork.

On October 9, 2008, Shionogi & Co., Ltd. ("Shionogi") and Shionogi announced the completion of Shionogi's acquisition of Shionogi. Shionogi is now an indirect wholly owned subsidiary of Shionogi.